JACOBS LEVY EQUITY MANAGEMENT, INC
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 884414
FLORHAM PARK, NJ
Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,228,870
-$116,008 QoQ
Shares Held
2,268
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#433
of 870 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. UTHR ranks #14 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
726,112 | $122,378,916 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
699,583 | $77,611,738 | |
| 3 | ZTS |
Zoetis Inc.
|
579,079 | $41,612,616 | |
| 4 | LQDA |
Liquidia Corp
|
240,752 | $19,195,156 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,065,964 | $17,117,708 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
377,085 | $9,242,353 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
199,800 | $5,068,926 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
4,273,026 | $4,871,249 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,228,870 | 2,268 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,344,878 | 2,268 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,105,083 | 2,268 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $950,768 | 2,268 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,279,834 | 7,934 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,445,814 | 7,934 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $800,241 | 2,268 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $812,737 | 2,268 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $722,471 | 2,268 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $521,004 | 2,268 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,375,428 | 74,471 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $43,519,728 | 192,676 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $49,570,957 | 224,557 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $57,622,668 | 257,290 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $88,722,667 | 319,043 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $76,553,306 | 365,619 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $78,045,617 | 331,207 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $61,999,790 | 345,576 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $83,352,643 | 385,749 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $90,077,254 | 488,012 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $88,065,013 | 490,859 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $84,453,786 | 504,895 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $76,340,200 | 502,933 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $53,385,166 | 528,566 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $54,602,218 | 451,258 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $34,573,121 | 364,580 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||